Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB
Mandate

Vinge advises Reig Jofré Group in connection with the business acquisition of Bioglan AB

September 07, 2009

Vinge has advised Reig Jofré Group in connection with the acquisition of the business of Bioglan AB from Midelfart Sonesson. Reig Joflé Group is one of the leading companies in Spain within the pharmaceuticals industry. Bioglan AB conducts operations in relation to contract development and manufacture of dermatological pharmaceuticals under the supervision of the Swedish Medical Products Agency.

Reig Jofré Group was advised by partner Peter Abrahamsson and associates Kristian Ford, Andreas Schöldström, Marcus Bergdahl, Anna Bjering and Anna Bergstrand.

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

 Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

 Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026